112 related articles for article (PubMed ID: 1030820)
41. [Distribution of erythromycin following intramuscular administration in laboratory animals].
Vyhnálek J
Vet Med (Praha); 1978 Oct; 23(10):623-31. PubMed ID: 102070
[TBL] [Abstract][Full Text] [Related]
42. Disposition kinetics of tylosin tartrate administered intravenously and intramuscularly to normal and water-deprived camels.
Ziv G; Creveld CV; Ben-Zvi Z; Glickman A; Yagil R
J Vet Pharmacol Ther; 1995 Aug; 18(4):299-305. PubMed ID: 8583543
[TBL] [Abstract][Full Text] [Related]
43. Antibacterial activity of serum of normal men after oral doses of erythromycin propionate and triacetyloleandomycin.
HIRSCH HA; KUNIN CM; FINLAND M
N Engl J Med; 1959 Feb; 260(9):408-12. PubMed ID: 13632901
[No Abstract] [Full Text] [Related]
44. Disposition kinetics and urinary excretion of pefloxacin after intravenous injection in crossbred calves.
Srivastava AK; Dumka VK; Deol SS
Vet Res Commun; 2000 Apr; 24(3):189-96. PubMed ID: 10836277
[TBL] [Abstract][Full Text] [Related]
45. Selection of an aminoglycoside antibiotic for administration to horses.
Baggot JD; Love DN; Rose RJ; Raus R
Equine Vet J; 1985 Jan; 17(1):30-4. PubMed ID: 3979370
[TBL] [Abstract][Full Text] [Related]
46. Comparative pharmacokinetics of macrolides.
Nilsen OG
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():81-8. PubMed ID: 3323170
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics of sulfadimethoxine in cats.
Baggot JD
Aust J Exp Biol Med Sci; 1977 Dec; 55(6):663-70. PubMed ID: 614834
[TBL] [Abstract][Full Text] [Related]
48. Effects of altered plasma alpha-1-acid glycoprotein levels on pharmacokinetics of some basic antibiotics in pigs: simulation analysis.
Kuroha M; Son DS; Shimoda M
J Vet Pharmacol Ther; 2001 Dec; 24(6):423-31. PubMed ID: 11903873
[TBL] [Abstract][Full Text] [Related]
49. Plasma concentration and disposition of antimicrobial agents in the dog.
English PB
Aust Vet J; 1983 Dec; 60(12):353-61. PubMed ID: 6365065
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetic-pharmacodynamic modeling of the inhibitory effect of erythromycin on tumour necrosis factor-alpha and interleukin-6 production.
Guchelaar HJ; Schultz MJ; van der Poll T; Koopmans RP
Fundam Clin Pharmacol; 2001 Dec; 15(6):419-24. PubMed ID: 11860530
[TBL] [Abstract][Full Text] [Related]
51. A comparison of the pharmacokinetics and tissue penetration of spiramycin and erythromycin.
Kavi J; Webberley JM; Andrews JM; Wise R
J Antimicrob Chemother; 1988 Jul; 22 Suppl B():105-10. PubMed ID: 3182434
[TBL] [Abstract][Full Text] [Related]
52. The penetration of erythromycin into human bronchial mucosa.
Mattie H; Hoogeterp JJ; Kaajan JP; Hermans J
Br J Clin Pharmacol; 1987 Aug; 24(2):179-83. PubMed ID: 3620291
[TBL] [Abstract][Full Text] [Related]
53. [New antibiotics, Josamycin. VI. Study on absorption and distribution of Josamycin].
Kuriaki K; Sado T; Sano K; Sasaki H; Shiobara Y
Jpn J Antibiot; 1969 Jun; 22(3):226-31. PubMed ID: 5306999
[No Abstract] [Full Text] [Related]
54. Enzymatic phosphorylation of macrolide antibiotics.
Wiley PF; Baczynskyj L; Dolak LA; Cialdella JI; Marshall VP
J Antibiot (Tokyo); 1987 Feb; 40(2):195-201. PubMed ID: 3570968
[TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetics of erythromycin in normal and alcoholic liver disease subjects.
Hall KW; Nightingale CH; Gibaldi M; Nelson E; Bates TR; DiSanto AR
J Clin Pharmacol; 1982 Jul; 22(7):321-5. PubMed ID: 7107981
[TBL] [Abstract][Full Text] [Related]
56. The relation between plasma and tissue concentrations of antibiotics. Description of a method.
Mattie H; Hoogeterp JJ; Hermans J
J Pharmacokinet Biopharm; 1987 Apr; 15(2):191-202. PubMed ID: 3612501
[TBL] [Abstract][Full Text] [Related]
57. [Comparative pharmacokinetics of erythromycin target cell-associated transport and intravenous administration in patients with pneumonia].
Gurevich KG; Piataev NA; Beliaev AN; Romanov MD
Antibiot Khimioter; 2006; 51(9-10):13-7. PubMed ID: 18030786
[TBL] [Abstract][Full Text] [Related]
58. Micromethod for assaying serum levels of erythromycin.
Bell SC; Hamman JW; Grundy WE
Appl Microbiol; 1969 Jan; 17(1):88-92. PubMed ID: 5774765
[TBL] [Abstract][Full Text] [Related]
59. Intersubject and dose-related variability after intravenous administration of erythromycin.
Austin KL; Mather LE; Philpot CR; McDonald PJ
Br J Clin Pharmacol; 1980 Sep; 10(3):273-9. PubMed ID: 7437245
[TBL] [Abstract][Full Text] [Related]
60. [Toxicological studies of Pharmachem's tylosin phosphate].
Donev B; Stoianov K; Kamenska M; Tomasini L
Vet Med Nauki; 1978; 15(4):54-62. PubMed ID: 741638
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
